Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Raleigh-Durham, North Carolina Clinical Trials

A listing of Raleigh-Durham, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (81) clinical trials

Environmental Polymorphisms Registry

We are establishing a registry-based cohort and repository of biological (e.g. blood, urine,saliva, etc.) and environmental (e.g. household dust) specimens (approximately 20,000 participants) in which the donated specimens are linked to the donor s identities, contact information, and some basic demographics through a personal identification number (PIN). Specimens are available ...

Phase N/A

0.0 miles

Learn More »

Study of Exposure to Chemicals in Consumer Products

Research to advance the characterization of environmental and chemical exposures through improved exposure assessments, at both the individual and population levels, is a research priority identified in the Strategic Research Action Plan for the U.S. Environmental Protection Agency (EPA) s Chemical Safety for Sustainability (CSS) program (EPA 2012) and the ...

Phase N/A

0.0 miles

Learn More »

Longitudinal MR Imaging of Pulmonary Function in Patients Receiving Thoracic Radiation Treatment

The purpose of this study is to determine whether magnetic resonance imaging (MRI) using inhaled hyper polarized xenon-129 (129Xe) gas, and conventional contrast can help visualize impaired lung function and detect changes over time in patients receiving treatment as well as those who don't. 129Xe is a special type of ...

Phase

3.14 miles

Learn More »

Trial of 4-OHT Gel in Women Aimed at Reducing Dense Breast Tissue

This is a randomized, double blind, placebo-controlled study. Subjects will have been assessed as having mammographically dense breast (heterogeneously dense (C) or extremely dense (D), based on the American College of Radiology (ACR) Breast Imaging-Reporting and Data System (BIRADS) fifth edition classification) for eligibility. Approximately 330 subjects will be enrolled ...

Phase

3.14 miles

Learn More »

Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis

The purpose of this study is to determine whether magnetic resonance imaging (MRI) using inhaled hyperpolarized 129Xe gas, and conventional contrast can help visualize impaired lung function and detect changes over time in patients receiving treatment as well as those who don't. 129Xe is a special type of xenon gas ...

Phase

3.14 miles

Learn More »

AMPLEX Ankle Fusion

To demonstrate that AMPLEX is non-inferior to autogenous bone graft (ABG) for bone fusion in a population indicated for single, double, or triple hindfoot arthrodesis or ankle arthrodesis surgery with supplemental graft material.

Phase N/A

5.56 miles

Learn More »

Qualitative Study of Black-White Sleep Disparities

OBJECTIVE Prior research has documented racial differences in sleep health by occupational class. While increasing professional responsibility has been associated with shorter sleep duration among non-Hispanic Blacks, increasing professional responsibility appears to be associated with a lower prevalence of short sleep duration among non-Hispanic Whites. The objective of the present ...

Phase N/A

5.67 miles

Learn More »

Evaluation of Dupilumab in Children With Uncontrolled Asthma

The total study duration per patient will be up to 69 weeks, consisting of a screening period of 3-5 weeks, a randomized treatment period of 52 weeks and a post-treatment period of 12 weeks.

Phase

6.6 miles

Learn More »

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

This is a prospective, noninterventional (no treatment medication provided by the study), observational (study in which the investigators/ physicians observe the patients and measure their outcomes), multicenter (study conducted at multiple sites) study of Golimumab IV and Infliximab in RA patients. The study allows for an anticipated 2-year enrollment period ...

Phase N/A

6.66 miles

Learn More »

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biologic disease modifying antirheumatic drug (bDMARD) nave participants with nonradiographic axial spondyloarthritis (nonrad-axSpA).

Phase

6.66 miles

Learn More »